GENEVA, July 31 -- SANEGENE BIO USA INC. filed a patent application (CN2026/075146) for “SMALL INTERFERING RNA TARGETING ACVR1C AND USES THEREOF”. With publication no. WO/2026/158693, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 31/7088
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....